These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11193181)

  • 1. Clinical and neuropathological correlates of dementia with Lewy bodies.
    Gómez-Tortosa E; Irizarry MC; Gómez-Isla T; Hyman BT
    Ann N Y Acad Sci; 2000; 920():9-15. PubMed ID: 11193181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.
    Gómez-Tortosa E; Newell K; Irizarry MC; Sanders JL; Hyman BT
    Acta Neuropathol; 2000 Apr; 99(4):352-7. PubMed ID: 10787032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and quantitative pathologic correlates of dementia with Lewy bodies.
    Gómez-Tortosa E; Newell K; Irizarry MC; Albert M; Growdon JH; Hyman BT
    Neurology; 1999 Oct; 53(6):1284-91. PubMed ID: 10522886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
    Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
    Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy body-related alpha-synucleinopathy in aging.
    Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Marui W; Togo T; Katsuse O; Kato M; Isojima D; Akatsu H; Kosaka K; Arai H
    Neuropathology; 2005 Sep; 25(3):188-94. PubMed ID: 16193834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and development of Lewy pathology: a critical update.
    Jellinger KA
    J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry.
    Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
    Neurosci Lett; 2000 May; 286(1):69-73. PubMed ID: 10822155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset dementia with Lewy bodies.
    Takao M; Ghetti B; Yoshida H; Piccardo P; Narain Y; Murrell JR; Vidal R; Glazier BS; Jakes R; Tsutsui M; Spillantini MG; Crowther RA; Goedert M; Koto A
    Brain Pathol; 2004 Apr; 14(2):137-47. PubMed ID: 15193026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia with Lewy bodies.
    Gómez-Tortosa E; Ingraham AO; Irizarry MC; Hyman BT
    J Am Geriatr Soc; 1998 Nov; 46(11):1449-58. PubMed ID: 9809770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.